Why is Mounjaro in Such High Demand?
Mounjaro, known as the “King Kong of weight loss drugs”, will be available to patients on the NHS, but this week it was announced the medication will be prioritised to people with the highest needs – with the rollout expected to extend over 12 years.
We take a look at why the medication is in such demand and the impact it could have on the nation’s health.
What is Mounjaro? Mounjaro is one of a growing number of weight loss jabs and is produced by the pharmaceutical company Eli Lilly. It is a once-a-week injection that contains the drug tirzepatide and is also used to help improve blood sugar in people with type 2 diabetes.
Excerpted from The Guardian
